Terms: = Cervical cancer AND MYH11, ENSG00000133392, 4629
2 results:
1. Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
Dua R; Bhardwaj T; Ahmad I; Somvanshi P
PLoS One; 2024; 19(4):e0287864. PubMed ID: 38626166
[TBL] [Abstract] [Full Text] [Related]
2. Therapy-related leukemia with Inv(16)(p13.1q22) and type D CBFB/myh11 developing after exposure to irinotecan-containing chemoradiotherapy.
Akiyama H; Yamamoto M; Sakashita C; Umezawa Y; Kurosu T; Murakami N; Miura O
Intern Med; 2015; 54(6):651-5. PubMed ID: 25786458
[TBL] [Abstract] [Full Text] [Related]
